Our research group has been established in 2013 by György M. Keserű on the basis of a preceding synthetic organic chemistry group.
Since then we established national and international, government and industry founded research programs focusing on the following major topics:
- fragment based approaches in the lead discovery of GPCR and kinase targets
- chemical process development for small molecule active pharmaceutical ingredients
- design and synthesis of targeted covalent inhibitors (TCIs)
You can follow us on Twitter or Mastodon, and view older posts on our Twitter timeline or our archived news page here.